Literature DB >> 12916924

Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry.

Makoto Otsuka1, Fumie Kato, Yoshihisa Matsuda.   

Abstract

The effect of humidity on the physicochemical properties of amorphous forms of cimetidine was investigated using differential scanning calorimetry, isothermal microcalorimetry, and x-ray diffraction analysis. Amorphous forms were obtained by the melting (amorphous form M [AM]) and the cotton candy (amorphous form C [AC]) methods. Thermal behaviors of AM and AC with or without seed crystals were measured using an isothermal microcalorimeter under various conditions of relative humidity (RH) and temperature, respectively. The crystallization kinetics of amorphous solids was analyzed based on 10 kinds of solid-state reaction models. AM transformed into form A at 11% RH, 50 degrees C but transformed into a mixture of form A and monohydrate at 51% and 75% RH at 25 degrees C. The mean crystallization times (MCTs) of the heat flow curve of AM and AC at 11% RH, 50 degrees C were 47.82 and 32.00 hours, respectively, but at 11% RH, 25 degrees C both were more than 4320 hours. In contrast, AC transformed into form A under all storage conditions. The MCTs of AC at 51% and 75% RH were 29.61 and 11.81 hours, respectively; whereas the MCTs of AM were 46.79 and 15.52 hours, respectively. The crystallization of amorphous solids followed the three-dimensional growth of nuclei (Avrami equation) with an induction period (IP). The IP for AM at 11% RH, 50 degrees C was more than 2 times that for AC, but the difference in the crystal growth rate constant (CR) between AC and AM was within 10%. The IP for AM at 75% RH, 25 degrees C was reduced to only 10% of the IP at 51% RH with increasing humidity, but the CR did not change significantly. In contrast, the IP for AC was slightly reduced at 75% RH compared with 51% RH, but the CR was about 5 times greater. At 75% RH, 25 degrees C, the IP and CR of AM were about one-fourth the values of AC. This result suggests that the crystallization process consists of an initial stage during which the nuclei are formed and a final stage of growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12916924      PMCID: PMC2751338          DOI: 10.1208/pt030430

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  8 in total

1.  Application of isothermal microcalorimetry in solid state drug development.

Authors: 
Journal:  Pharm Sci Technolo Today       Date:  2000-01

2.  Characterization of habits and crystalline modification of solids and their pharmaceutical applications.

Authors:  J K Haleblian
Journal:  J Pharm Sci       Date:  1975-08       Impact factor: 3.534

3.  Pharmaceutical microcalorimetry: applications to long-term stability studies.

Authors:  A E Beezer; S Gaisford; A K Hills; R J Willson; J C Mitchell
Journal:  Int J Pharm       Date:  1999-03-15       Impact factor: 5.875

4.  Use of microcalorimetry in monitoring stability studies. Example: vitamin A esters.

Authors:  F E Runge; R Heger
Journal:  J Agric Food Chem       Date:  2000-01       Impact factor: 5.279

5.  The polymorphism of cimetidine.

Authors:  B Hegedüs; S Görög
Journal:  J Pharm Biomed Anal       Date:  1985       Impact factor: 3.935

6.  X-ray structural studies and physicochemical properties of cimetidine polymorphism.

Authors:  M Shibata; H Kokubo; K Morimoto; K Morisaka; T Ishida; M Inoue
Journal:  J Pharm Sci       Date:  1983-12       Impact factor: 3.534

7.  Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products.

Authors:  Y Tanigawara; K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharm Sci       Date:  1982-10       Impact factor: 3.534

8.  Development of a flow microcalorimetry method for the assessment of surface properties of powders.

Authors:  P L Sheridan; G Buckton; D E Storey
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

  8 in total
  3 in total

1.  Crystal structure transformations and dissolution studies of cimetidine-piroxicam coprecipitates and physical mixtures.

Authors:  Vimon Tantishaiyakul; Sarunyoo Songkro; Krit Suknuntha; Pattakarn Permkum; Pattawee Pipatwarakul
Journal:  AAPS PharmSciTech       Date:  2009-06-12       Impact factor: 3.246

2.  Effect of tablet geometrical structure on the dehydration of creatine monohydrate tablets, and their pharmaceutical properties.

Authors:  Yukoh Sakata; Sumihiro Shiraishi; Makoto Otsuka
Journal:  AAPS PharmSciTech       Date:  2005-10-26       Impact factor: 3.246

3.  Preparation and physicochemical characterization of 5 niclosamide solvates and 1 hemisolvate.

Authors:  Elsa C van Tonder; Mabatane D Mahlatji; Sarel F Malan; Wilna Liebenberg; Mino R Caira; Mingna Song; Melgardt M de Villiers
Journal:  AAPS PharmSciTech       Date:  2004-02-23       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.